共 131 条
[1]
Hellers G(1980)Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease Gut. 21 525-7
[2]
Bergstrand O(2011)Incidence and clinical outcomes of intersphincteric abscesses diagnosed by anal ultrasonography in patients with Crohn’s disease Inflamm Bowel Dis. 17 2102-8
[3]
Ewerth S(2004)Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula Br J Surg. 91 476-80
[4]
Holmstrom B(2010)Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn’s disease: when and how were the seton drains removed? Hepatogastroenterology. 57 3-7
[5]
Vigano C(2010)Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano Dis Colon Rectum. 53 486-95
[6]
Losco A(2006)Infliximab in fistulizing Crohn’s disease Gastroenterol Clin North Am. 35 795-820
[7]
Caprioli F(1999)Infliximab for the treatment of fistulas in patients with Crohn’s disease N Engl J Med. 340 1398-405
[8]
Basilisco G(2010)The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy Aliment Pharmacol Ther. 32 1228-39
[9]
Buchanan GN(2001)Clinical use of infliximab in Crohn’s disease: the Edinburgh experience Aliment Pharmacol Ther. 15 1639-46
[10]
Owen HA(2002)Infliximab in treatment of Crohn’s disease: the Milan experience Dig Liver Dis. 34 411-8